New G-protein-coupled receptor crystal structures: insights and limitations

Trends in Pharmacological Sciences

Volumn 29, Issue 2, 2008, Pages 79-83

  Kobilka, Brian ^a   Schertler, Gebhard F X ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CARAZOLOL; G PROTEIN COUPLED RECEPTOR; HYBRID PROTEIN; LYSOZYME; RHODOPSIN;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

CRYSTALLOGRAPHY, X-RAY; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED;

EID: 38749131545     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2007.11.009     Document Type: Article

References (40)

1. Sakmar T.P., et al. Rhodopsin: insights from recent structural studies. Annu. Rev. Biophys. Biomol. Struct. 31 (2002) 443-484
2. Hubbell W.L., et al. Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Adv. Protein Chem. 63 (2003) 243-290
3. Palczewski K. G protein-coupled receptor rhodopsin. Annu. Rev. Biochem. 75 (2006) 743-767
4. Krebs A., et al. The three-dimensional structure of bovine rhodopsin determined by electron cryomicroscopy. J. Biol. Chem. 278 (2003) 50217-50225
5. Krebs A., et al. Characterisation of an improved two-dimensional p22121 crystal from bovine rhodopsin. J. Mol. Biol. 282 (1998) 991-1003
6. Schertler G.F. Structure of rhodopsin. Eye 12 (1998) 504-510
7. Unger V.M., et al. Arrangement of rhodopsin transmembrane alpha-helices. Nature 389 (1997) 203-206
8. Schertler G.F., et al. Projection structure of rhodopsin. Nature 362 (1993) 770-772
9. Okada T., et al. X-Ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. J. Struct. Biol. 130 (2000) 73-80
10. Palczewski K., et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289 (2000) 739-745
11. Okada T., et al. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 5982-5987
12. Teller D.C., et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40 (2001) 7761-7772
13. Okada T., et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J. Mol. Biol. 342 (2004) 571-583
14. Li J., et al. Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343 (2004) 1409-1438
15. Standfuss J., et al. Crystal structure of a thermally stable rhodopsin mutant. J. Mol. Biol. 372 (2007) 1179-1188
16. Rasmussen S.G., et al. Crystal structure of the human beta(2) adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
17. Cherezov V., et al. High-resolution crystal structure of an engineered human {beta}2-Adrenergic G protein coupled receptor. Science 318 (2007) 1258-1265
18. Rosenbaum D.M., et al. GPCR Engineering yields high-resolution structural insights into {beta}2 adrenergic receptor function. Science 318 (2007) 1266-1273
19. Lefkowitz R.J. The superfamily of heptahelical receptors. Nat. Cell Biol. 2 (2000) E133-E136
20. Kobilka B.K. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal. Biochem. 231 (1995) 269-271
21. Kobilka B.K., and Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol. Sci. 28 (2007) 397-406
22. Day P.W., et al. A monoclonal antibody for G protein-coupled receptor crystallography. Nat. Methods 4 (2007) 927-929
23. Iwata S., et al. Structure at 2.8 A resolution of cytochrome c oxidase from Paracoccus denitrificans. Nature 376 (1995) 660-669
24. Zhou Y., et al. Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 A resolution. Nature 414 (2001) 43-48
25. Landau E.M., and Rosenbusch J.P. Lipidic cubic phases: a novel concept for the crystallization of membrane proteins. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 14532-14535
26. Caffrey M. Membrane protein crystallization. J. Struct. Biol. 142 (2003) 108-132
27. Cusack S., et al. Small is beautiful: protein micro-crystallography. Nat. Struct. Biol. 5 Suppl (1998) 634-637
28. Riekel C., et al. Protein crystallography microdiffraction. Curr. Opin. Struct. Biol. 15 (2005) 556-562
29. Lefkowitz R.J., and Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 308 (2005) 512-517
30. Ballesteros J.A., et al. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276 (2001) 29171-29177
31. Yao X., et al. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat. Chem. Biol. 2 (2006) 417-422
32. Farrens D.L., et al. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274 (1996) 768-770
33. Kim J.M., et al. Light-driven activation of beta 2-adrenergic receptor signaling by a chimeric rhodopsin containing the beta 2-adrenergic receptor cytoplasmic loops. Biochemistry 44 (2005) 2284-2292
34. Cerione R.A., et al. Specificity of the functional interactions of the β-adrenergic receptor and rhodopsin with guanine nucleotide regulatory proteins reconstituted in phospholipid vesicles. J. Biol. Chem. 260 (1985) 1493-1500
35. Pardo L., et al. The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors. Chem BioChem 8 (2007) 19-24
36. Blundell T.L., et al. Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361 (2006) 413-423
37. Carr R.A., et al. Fragment-based lead discovery: leads by design. Drug Discov. Today 10 (2005) 987-992
38. Hajduk P.J., and Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat. Rev. Drug Discov. 6 (2007) 211-219
39. Ghanouni P., et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J. Biol. Chem. 276 (2001) 24433-24436
40. Pellecchia M., et al. NMR in drug discovery. Nat. Rev. Drug Discov. 1 (2002) 211-219